Work

MA 12.07 Adjusted Indirect Comparison of Osimertinib to Chemotherapy in NSCLC Patients with EGFRm T790M Who Progressed after EGFR-TKI

Year: 2017

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2017.09.556

Authors: C. Hoyle, F. Andersohn, T. Mitsudomi, T. Mok, J.C. Yang, M. Green, H. Mann

Institutions: AstraZeneca (United Kingdom), Charité – Universitätsmedizin Berlin, Kindai University, Chinese University of Hong Kong, National Taiwan University Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2767679262

FWCI:

Cites:

Cited by:

Related to: 10